Sweat Sensor Could Track Bowel Disease Inflammation

Early research suggests people with inflammatory bowel disease may one day monitor inflammation through perspiration instead of blood draws.

Updated on Nov. 7, 2026 in Diseases

Small flexible sweat-sensing patch with a curved sensor pad resting on a pale laboratory bench beside an empty glass dish, in soft daylight.
Researchers at the University of Texas at Dallas found a noninvasive sweat sensor can detect inflammation markers in 33 patients with inflammatory bowel disease, published in Inflammatory Bowel Diseases. AI Illustration. Upload story photo >

Researchers at the University of Texas at Dallas tested a noninvasive sensor that measures inflammation markers in perspiration from patients with inflammatory bowel disease. The cross-sectional study enrolled 33 patients, and the findings were published in Inflammatory Bowel Diseases, with relevance for people managing IBD who want less invasive monitoring options.

Why it matters

Inflammatory bowel disease is typically tracked through blood draws and stool tests, which can be uncomfortable and infrequent. A wearable that samples sweat could, if validated in larger studies, offer a way to monitor inflammation more often and with less burden.

This cross-sectional study enrolled 33 patients with inflammatory bowel disease and compared sensor readings from perspiration against blood and stool samples taken at the same time. Because it was a single-timepoint design in a small group, the results are preliminary and do not yet show that sweat readings predict disease activity.

The players

University of Texas at Dallas

A Dallas-based public research university whose researchers developed the noninvasive perspiration sensor tested in this study.

The details

The sensor continuously collects perspiration while worn and measures C-reactive protein, a marker of systemic inflammation, and calprotectin, a protein released by inflammatory cells in the gut. Investigators compared these sweat-based readings with serum and stool measurements from the same patients. Patients with Crohn's disease showed higher median CRP levels in both sweat and serum, while patients with ulcerative colitis showed higher median calprotectin levels.

Timeline

  1. The study results were published in Inflammatory Bowel Diseases; the exact publication date was not provided in the source extraction.

Health Landscape

Current IBD monitoring relies on periodic blood tests for CRP and stool tests for calprotectin, which are accurate but require repeated invasive or inconvenient collection. This study adds an early proof-of-concept for a wearable alternative, though it remains far from routine clinical use.

If you have inflammatory bowel disease, this research is an early signal that sweat-based monitoring may someday supplement blood and stool tests, but it is not available today. Keep following your current monitoring plan and raise questions about inflammation tracking with your gastroenterologist at your next visit.

The takeaway

Noninvasive monitoring could make tracking inflammation easier for people with IBD once validated in larger studies. Until then, continue your prescribed monitoring and discuss any questions about testing frequency with your doctor.

Further reading

Explore more on Diabetes and related metabolic and chronic-condition coverage in Dallas.

Source note: This article includes information reported by Derm Immuno Today.